跳至主要内容
临床试验/NCT06038864
NCT06038864尚未招募不适用

Development of a Clinical Screening, Diagnostic and Evaluation Tool for Patients With Lower Limb Lymphedema: Development of an Evaluation Set for Patients With LLL

KU Leuven2 个研究点 分布在 2 个国家目标入组 120 人开始时间: 2024年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
KU Leuven
入组人数
120
试验地点
2
主要终点
Specificity of measurement methods

研究概览

简要总结

Research investigating measurement properties for evaluating the decongestive treatment effect on different edema characteristics (e.g. water volume, hardness of the skin, water content,..) at the level of the lower limbs is missing. Information about the clinical relevant change criteria after treatment for nearly all these edema characteristics, is not present and requires investigation.

To assess the merits of each treatment in a reproducible manner, a reliable way of measuring limb volume and other edema characteristics must be established, as the evaluation of treatment effects without appropriate tools might lead to biased treatment effects.

First of all, in clinical practice, it is of utmost importance to know which edema characteristics need to be evaluated in order to assess the clinical evolution of a patient with lymphedema during and after treatment. Secondly, in order to draw proper conclusions about the treatment effect, it is necessary that to know from which criterion (or cut-off value) one can speak of a real clinical change for a certain lymphedema characteristic. Given that the edema characteristics that are most responsive to treatment and their corresponding criteria for clinically significant and relevant changes at the lower limbs have never been investigated before, the need for this research is high.

Therefore, the research questions in this study are: Which measurement tool(s) are able to detect clinically relevant changes in the lymphedema characteristics after the intensive treatment and during the maintenance treatment? When can a clinician speak of a clinically relevant change?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Intensive treatment group
  • Unilateral or bilateral, primary or secondary LLL
  • No active metastases
  • If cancer-related lymphedema, time interval since surgery/ radiotherapy/ chemotherapy is ≥3 months
  • Objective diagnosis of lymphedema: ≥ 5% volume difference OR ≥ 2 minor/ 1 major criteria on lymphoscintigraphy OR presence of ICG dermal backflow
  • Age ≥ 18 years
  • Able to read, understand and speak Dutch
  • Planned to start with intensive decongestive lymphatic therapy at one or both legs
  • Maintenance treatment group
  • See inclusion criteria 'intensive treatment group'
  • But: instead of patients planned to start with intensive lymphatic therapy, patients of this group should have ended their intensive treatment phase at least 3 months ago (= currently receiving maintenance decongestive lymphatic therapy)

排除标准

  • Pregnant participants
  • Presence of chronic venous insufficiency C4, C5, C6; deep venous thrombosis; post-thrombotic syndrome
  • Presence of skin infections of wounds at the level of the lower limbs at the moment of inclusion

结局指标

主要结局

Specificity of measurement methods

时间窗: 1 month

Specificity of measurement methods (resulting from aim 1:NCT05269264) in the evaluation of the treatment effect over time in patients with unilateral and bilateral LLL. Patients will be evaluated twice with 1 month in between.

Diagnostic accuracy of measurement methods

时间窗: 1 month

Diagnostic accuracy (in terms of area under the curve using a ROC curve, as well as sensitivity and specificity) of measurement methods (resulting from aim 1:NCT05269264) in the evaluation of the treatment effect over time in patients with unilateral and bilateral LLL. Patients will be evaluated twice with 1 month in between.

Sensitivity of measurement methods

时间窗: 1 month

Sensitivity of measurement methods (resulting from aim 1:NCT05269264) in the evaluation of the treatment effect over time in patients with unilateral and bilateral LLL. Patients will be evaluated twice with 1 month in between.

次要结局

  • Lymphedema volume after 4 weeks of intensive DLT in patients with unilateral and bilateral LLL(1 month)
  • Hardness of skin after 4 weeks of intensive DLT in patients with unilateral and bilateral LLL(1 month)
  • Piiting status after 4 weeks f intensive DLT in patients with unilateral and bilateral LLL(1 month)
  • Skinfold thickness after 4 weeks of intensive DLT in patients with unilateral and bilateral LLL(1 month)
  • Extracellullar fluid after 4 weeks of intensive DLT in patients with unilateral and bilateral LLL(1 month)
  • Problems in functioning after 4 weeks of intensive DLT in patients with unilateral and bilateral LLL(1 month)

研究者

发起方
KU Leuven
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tessa De Vrieze

Principal investigator

KU Leuven

研究点 (2)

Loading locations...

相似试验